))
David Steinberg _e.040
Manage episode 375009462 series 3006114
Content provided by John Flavin. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by John Flavin or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
e.040: David Steinberg is a General Partner at Longwood Fund. He is currently Chairman of the Board of Longwood portfolio companies Photys Therapeutics and Be Biopharma, where he also served as founding Chief Executive Officer, and serves on the board of Longwood portfolio companies AAVantgarde Bio, Carbon Biosciences, Lassen Therapeutics, and Rectify Pharmaceuticals.Previously, he was co-founder and Chief Innovation Officer of biotech venture creation firm PureTech Health (NASDAQ: PRTC), focusing on launching and investing in innovative biotech companies. David was the co-founder and CEO of several biotech companies, including Longwood-founded companies Pyxis Oncology (NASDAQ:PYXS) , Photys Therapeutics, Be Biopharma, and Carbon Biosciences as well as co-founder and CEO of Vor Biopharma (NASDAQ: VOR), Vedanta Biosciences, and Calix, and co-founder of Restorbio (NASDAQ:TORC). He previously worked in biopharma strategy consulting at Boston Consulting Group and Vertex Partners, and R&D at P&G Pharmaceuticals. David received his MBA in strategy and finance from the University of Chicago Booth School of Business and holds a BA in biology from Cornell University.
56 episodes
Share
